Pirminė plaučių plazmacitoma: klinikinis atvejis by Arsovski, Andreja et al.
252
Primary pulmonary plasmacytoma: a case report
Pirminė plaučių plazmacitoma: klinikinis atvejis
Andreja Arsovski1, Liljana Stojanovska2, Sasho Banev3, Zoran Dimitrov4
1 Private General Hospital “Remedika”, Department of Surgery, 16-ta Makedonska brigada Str., No. 18, 1000 Skopje, 
Macedonia
 E-mail: arsovskia@yahoo.com; aarsovski@remedika.com.mk
2 Private General Hospital “Remedika”, Department of Surgery, 16-ta Makedonska brigada Str., No. 18, 1000 Skopje, 
Macedonia
 E-mail: stojanovska_liljana@yahoo.com
3 Private Health Institution Laboratory of Cytology and Histology “Biopsy”, Vasil Levski Str., No. 1A, 1000 Skopje, 
Macedonia
 E-mail: banevs@freemail.com.mk
4 Public Healthcare Institution “General Hospital Gevgelija”, Department of Surgery, Slobodan Mitrov - Danko Str.,  
No. 38, 1480 Gevgelija, Macedonia
 E-mail: dimitrov_zoran@yahoo.com
Background
Extramedullary plasmacytoma is a plasma cell malignancy that most commonly occurs in the upper respiratory tract. These 
tumors account for less than 5% from all plasma cell neoplasms. In most of the cases, tumor first appears in the mucosa of the 
upper respiratory tract, mainly in the paranasal sinuses. When only located in the lower respiratory tract (primary pulmonary 
plasmacytoma), the diagnosis is difficult and is usually based on the pathological findings from excised tissue.
Case report
We present one case of primary pulmonary plasmacytoma, which accidentally was diagnosed in our hospital, and this is the 
first case of primary pulmonary plasmacytoma reported in our country. In the present article, we describe a primary pul-
monary plasmacytoma (PPP) of the right lower lobe without loco-regional lymph node involvement, treated radically. The 
histological finding was confirmed by immunohistochemistry. There was no clinical evidence for the presence of multiple 
myeloma.
Conclusion
Primary pulmonary plasmacytoma present a rare neoplasm which could be differentially diagnostically classified as adeno-
carcinoma. The diagnosis of this tumor is based on pathological findings from excised tissue. The radical surgical treatment 
presents primary treatment option and, if there are no signs of the dissemination of the disease or of the presence of multiple 
myeloma, adjuvant chemotherapy is not needed.
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Introduction
Extramedullary plasmacytoma is a plasma cell ma-
lignancy that most commonly occurs in the upper 
respiratory tract. These tumors account for less than 
5% of all plasma cells neoplasms [1]. In most of the 
cases, tumor first appears in the mucosa of the upper 
respiratory tract, mainly in the paranasal sinuses [2]. 
Plasmacytoma located in the lung is an unusual find-
ing, and in such cases the disease may be confined to 
the lung and regional lymph nodes or may be dissemi-
nated [3]. When only located in the lower respiratory 
tract (primary pulmonary plasmacytoma), the diagno-
sis is difcult and is usually based on the pathological 
findings from excised tissue [3]. These tumors seldom 
produce paraprotein, but those that do are generally 
associated with immunoglobulin (Ig) G kappa mono-
clonal gammopathy [4]. 
We present one case of primary pulmonary plas-
macytoma, which accidentally was diagnosed in our 
hospital, and this is the first case of primary pulmonary 
plasmacytoma reported in our country.
In the present article, we describe a primary pul-
monary plasmacytoma (PPP) of the right lower lobe 
without loco-regional lymph node involvement, treated 
radically. The histological finding was confirmed by im-
munohistochemistry and there was no clinical evidence 
for the presence of multiple myeloma (MM).
Primary pulmonary plasmacyroma (PPP) is a rare 
plasma cell neoplasm and in the medical literature is 
described only as case reports.
Case report 
In our report, we present a case of 72-year-old male 
patient with the history of 20 years of type 2 diabetes 
mellitus. More than two years he is on insulin treatment. 
In spite of this, he has a diagnosed arterial hyperten-
sion and signs and symptoms of weakened circulation in 
lower extremities, loss of toenails on the legs and trophic 
changes on the left foot. He is a non-smoker. The patient 
came to our hospital for the treatment of arterial insuf-
ficiency and trophic changes in the left foot.
The patient was advised by a vascular surgeon to make 
CT (computed tomography) angiography of the aorta 
and large blood vessels of the lower extremities.
Radiological findings
CT angiography of the aorta and large blood vessels of 
the lower extremities was performed. Arterial circulation 
in the fetlock of both lower limbs was significantly com-
promised by advanced atherosclerotic changes. Obstruc-
tion in arterial circulation in the right leg was dominant 
in the right anterior tibial artery and in the peroneal 
artery. In the left leg, the obstruction was dominant in 
two branches of the posterior tibial artery – peroneal 
artery and medial malleolar artery. 
Additionally, on the lung, the radiologist described 
a rounded nodular pathological mass in the right lower 
lobe. He advised to perform CT of the lung. 
In this patient, an enhanced chest CT scan with na-
tive series and a series after the intravenously adminis-
tered contrast were performed.
On the CT scan, in the right lower lobe, in the medial-
basal segment there was detected a circumscript, rounded 
tumorous consolidation with the dimension of 3 cm, 
clearly confined from the surrounding normal tissue.
The other findings of the lungs and mediastinum 
were without pathologic abnormalities. No enlarged lo-
co-regional lymph nodes were detected on the CT scan.
On virtually performed bronchoscopy from CT 
scans, an orderly transition of the tracheobronchial tract 
was detected. 
On CT series after intravenous administration of the 
contrast, pathologic consolidation seen in native series 
was detected as a pathologic abnormality with the reten-
tion of the administered contrast (Figure 1).
Percutaneous trans-thoracic needle core biopsy from 
the detected tumor in the right lower lobe was per-
formed. The patient was advised to consult a thoracic 
surgeon.
After consultation with the thoracic surgeon, addi-
tional examinations were performed.
Hematology findings
Hb – 125 g/L; Hct – 35.4%; RBC – 4.40 x 1012/L; 
WBC – 7.3 x 109/L; PLT – 243 x 109/L. 
Biochemistry findings
K – 4.58 mmol/L; Na – 140.4 mmol/L; Cl – 
99.3  mmol/L; urea – 5.5 mmol/L; creatinine – 
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64 µmol/L; albumin – 43 g/L; total proteins – 65 g/L, 
and CRP – 5.28 mg/L.
Pulmonary function test findings
FVC 3.51 L; FEV1 – 3.03 L; FEV1 / FVC 86.3%; 
PEF – 4.87 L/s; FEF25 – 4.60 L/s; FEF50 – 3.35 L/s; 
FEF75 – 1.81 L/s; FET 2.03 s.
Echocardiography findings
LVedd – 5 cm; LVesd – 3.6 cm; RV – 2.5 cm; MV – 
0.9 m/s; muscle mass – 198 g; EF – 57%; LV – with a 
medium diastolic dysfunction; RV – orderly function; 
mitral valve, aortic valve, pulmonary valve, tricuspid 
valve – with orderly function.
Cytology findings from trans-thoracic 
needle core biopsy
Cytology findings from tumor core biopsy show a solid 
to irregular gland-like architecture built from cylindrical 
cells with vacuolated cytoplasm and a large nucleus with 
separate mitosis, with suggestive mucin production. 
Cytological finding according to the pathologist was in 
favor of moderate differentiated solid adenocarcinoma 
of the lung (Figure 2).
Treatment 
According to the cytological diagnosis, CT finding and 
results obtained from other examinations, an indication 
for surgical treatment was established.
After the preoperative preparation of the patient for 
surgical intervention and the examination by the anes-
thesiologist, the patient was operated on under general 
anesthesia with a double-lumen endotracheal tube. 
A lateral, muscle-spearing thoracotomy was per-
formed. In the right lower lobe, a solid, rounded tumor 
mass with approximately 3 cm in the diameter was 
found.
Intraoperative vascular and bronchial staplers were 
used. A radical right lower lobectomy was performed 
without any intraoperative complications.
A loco-regional lymphadenectomy was done. Macro-
scopically excised lymph nodes were not enlarged. Two 
thoracic drains were placed. 
Figure 1. Enhanced chest computed tomography scan with 
intravenously administered contrast (A and B – CT scan 
reconstruction). Pathological mass with the retention of con-
trast – marked with arrows 
A
B
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Postoperatively, as an antibiotic treatment, amp. 
Clindamycin à 0,6 g 2 x 1 (Klimicin, Lek pharmaceuti-
cal company d.d. Ljubljana, Slovenia) was administered 
and a high epidural catheter for analgesia was placed.
The resected tissue was sent for pathological analysis. 
Thoracic drains were removed on the second and 
fourth postoperative days. Chest X-ray evaluation was 
performed on the first and fifth postoperative days 
(Figure 3).
Figure 3. Postoperative X-ray control evaluation. Status after 
right lower lobectomy with ordinary transparency of the right 
upper and middle lobes and the mediastinum dragged to the 
right
Figure 2. Cytological image (original magnification x 400).  
Hematoxylin and eosin staining of tumor biopsy. Solid to ir-
regular gland-like architecture of the cells
Figure 4. Hematoxylin and eosin staining of resected right 
lower lobe (4A). Immunohistochemical staining of tumor with 
antibodies to CD79α (4B)
B
A
The patient was discharged from our hospital on 
the seventh postoperative day, and the first control was 
carried out after seven days with orderly postsurgical 
findings.
Pathological finding
In the resected tissue, the pathologist found a macro-
scopically well visible circumscript, rounded, grey-white 
nodule 3 cm in diameter. The microscopic finding 
showed irregular sheets of atypical and normal plasma 
cells, and scanty fibro-vascular tissue was found between 
plasma cells (Figure 4, A). 
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Immunohistochemical analysis of the resected tumor 
showed a strong positive CD79α (Figure 4, B).
The differential diagnosis from pathological findings 
includes plasma cell granuloma (inflammatory neofibro-
blastic tumor), but the lack of mixed inflammatory cells 
and myofibroblastic cells favor the diagnosis of primary 
pulmonary plasmacytoma (PPP).
There was no evidence of MM in the subsequent 
bone marrow biopsy made after receiving the pathologi-
cal finding. At the same time, biochemistry finding for 
the urinary Bence–Jones protein was performed, and the 
result was negative. 
The final diagnosis of primary pulmonary plasmacy-
toma was made. 
Discussion
Extramedullar plasmacytoma is a monoclonal prolif-
eration of plasma cells in soft tissues or in organs. The 
relationship among multiple myeloma, solitary plasma-
cytoma of bone, and extramedullary plasmacytoma is 
not well understood. 
Extramedullary plasmacytoma should be regarded 
differently from primary plasma cell bone marrow 
tumors [2].
Extramedullary plasmacytoma in the upper airways is 
more common in men. The most usual age of the onset 
is 50 to 60 years, and clinical signs reflect the location 
of the tumor [3]. Primary pulmonary plasmacytoma 
evolves differently from multiple myeloma, and pro-
longed survival rates have been described. 
However, they are so rare that nothing is known 
about the prognosis. The 10-year overall survival rate 
from extramedullary plasmacytoma according to some 
studies is 70% [5].
In the largest series in the literature, 66% survived 
for 2 years and 40% for 5 years. Two patients survived 
for 20 years [6].
The rate of progression to multiple myeloma is lower 
than in solitary bone plasmacytoma, ranging within 
11–30% in 10 years [7].
The treatment for primary pulmonary plasmacytoma 
has not been fully established. Surgical resection can be 
considered curative if it is complete [8, 9].
In some of the surgically treated patients, radio-
therapy was performed as a post-operative treatment, 
and other patients were treated with radiotherapy and 
chemotherapy. There was no difference in the survival, 
although it is difcult to evaluate as the follow-up in-
formation is scanty.
After receiving the results of pathological findings, 
additional examinations were performed (bone marrow 
biopsy and urine test for the presence of the Bence–
Jones protein). The existence of multiple myeloma 
was excluded from the obtained result of bone marrow 
biopsy and negative urine test for the presence of the 
Bence–Jones protein.
The final diagnosis of primary pulmonary plasmacy-
toma was made.
After consultations with the hematologist and the 
oncologist, it was decided not to administer any ad-
ditional therapy.
The patient was advised to perform a routine check-
up every six months for monitoring of the further course 
the disease.
Conclusion
Primary pulmonary plasmacytoma presents a rare 
neoplasm which could diagnostically be classified as 
adenocarcinoma. The diagnosis of this tumor is based 
on pathological findings from excised tissue. The treat-
ment protocol for this neoplasm is not established due 
to the limited follow-up data only for a little number of 
patients. Radical surgical treatment presents the primary 
treatment option, and if there are no signs of the dis-
semination of the disease or of the presence of multiple 
myeloma, adjuvant chemotherapy is not needed.
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